Digital breast tomosynthesis (DBT) or 3-D mammography new installations (includes new equipment and 3-D upgradation) expected to reach 4,547 units in 2016, up from 4,061 units in 2015. In terms of revenues, the global digital breast tomosynthesis equipment market is expected to reach 1,007.6 Mn in 2016, witnessing a year-over-year growth of 13.7%.
Limitations concerning the flat nature of images achieved through a 2-D full-field digital mammography (FFDM) is influencing end-users to adopt DBT equipment for diagnosis of breast cancers. Digital breast tomosynthesis enables radiologists to analyse abnormalities lucidly, helping improve detection rates while reducing callbacks. In the backdrop of these factors, demand for digital breast tomosynthesis equipment is witnessing an uptick, and the trend is expected to gain further momentum in the future.
To remain ‘ahead’ of your competitors, request for a sample
Sales of DBTs have remained quite robust in the US in the recent past, making North America the most lucrative market globally. The market in the region is largely dominated by Hologic, Inc. although GE and Siemens Healthineers have also registered their presence by launching innovative DBT products at competitive prices. Total DBT equipment revenues in North America were pegged at 472.8 Mn in 2015, with the U.S. accounting for bulk of revenue share. New equipment installation base in North America is expected to reach 2,327 in 2016, up from 2,066 in 2015.
In addition to North America, digital breast tomosynthesis sales are also growing steadily in Western Europe and APEJ. Revenues in Western Europe are anticipated to grow by 13.4% in 2016, whereas APEJ is expected to increase at 12.2%.
By end-users, hospitals account for higher demand for DBTs vis-à-vis diagnostic centres. Many hospitals are in the process of upgrading their existing mammography machines, owing to which demand for DBT equipment is growing at a steady rate. However, high costs, coupled with lack of awareness can impede adoption rates in both hospitals and diagnostic centres, and slow down the growth of the market globally. Installations of DBTs in hospitals totalled 3,020 in 2015, representing a market value worth 542.8 Mn.
Key players in the global digital breast tomosynthesis equipment market include
- Hologic Inc.
- GE Healthcare
- Siemens Healthineers
- Internazionale Medico Scientifica
- Planmed Oy.
Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1241
The top 3 players
- Hologic, Inc.,
- GE Healthcare,
- Siemens Healthineers collectively account for nearly 90% revenue share of the market.
Drivers and Trends
Risk of developing cancer is directly proportional to age. Increasing life expectancy in developing countries and adoption of unhealthy lifestyles due to rampant urbanisation and westernisation are driving incidence rate of cancer among the population in these countries. Although, incidence of breast cancer has reduced in developed countries due to several preventive measures implemented by various government and non-governmental organisations, incidence rate of breast cancer is increasing at a steady rate.
These factors are expected to increase the prevalence and diagnosis of breast cancer over the forecast period. DBT machines, with their superior sensitivity and specificity in comparison to conventional 2D mammography, reduces false positive recalls and offers better cancer detection especially, invasive cancer detection. DBT reduces the need to revisit for additional breast imaging by around 15%, thereby reducing costs, psychological distress, time and discomfort caused by a false negative recall. DBT equipment manufacturers are providing software and hardware upgrades for existing full film digital mammography systems which addresses the financial impact of buying new equipment.
Key Segments Covered
By Product type
- DBT Equipment
- 3-D Upgradation
By End User
- Diagnostic centres
For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1241
Key Regions Covered
- North America
- Latin America
- Western Europe
- Eastern Europe